Goldman Sachs raised its price target on Abbvie (NYSE: ABBV) to $100.00 (from $85.00) while maintaining a Buy rating.Analyst Jami ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE